STAT+: Scientists are pushing to get their grants reinstated — and some are winning
The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby and sue to restore funding.

The grant termination letters sting.
Study after study gets spiked because it “no longer effectuates agency priorities.”
If the research hints at diversity, equity, or inclusion, the wording gets a little nasty, in the view of neurologist Charles DeCarli, chair in Alzheimer’s research at the University of California, Davis. His $53 million inquiry into how vascular factors contribute to dementia among white, Black, and Hispanic people was terminated in March.